Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Establishment of multi-stage intravenous self-administration paradigms in mice

    Genetically tractable animal models provide needed strategies to resolve the biological basis of drug addiction. Intravenous self-administration (IVSA) is the gold standard for modeling psychostimulant and opi...

    Lauren M. Slosky, Andrea Pires, Yushi Bai, Nicholas B. Clark in Scientific Reports (2022)

  2. Article

    Open Access

    A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion

    Field cancerization is a premalignant process marked by clones of oncogenic mutations spreading through the epithelium. The timescales of intestinal field cancerization can be variable and the mechanisms drivi...

    Peter G. Boone, Lauren K. Rochelle, Joshua D. Ginzel in Nature Communications (2019)

  3. No Access

    Article

    Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept

    5-hydroxytryptophan (5-HTP) has shown therapeutic promise in a range of human CNS disorders. But native 5-HTP immediate release (IR) is poorly druggable, as rapid absorption causes rapid onset of adverse event...

    Jacob P. R. Jacobsen, Adrianna Oh, Rachel Bangle in Neuropsychopharmacology (2019)

  4. Article

    Open Access

    Adipocyte β-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis

    β-Arrestins are major regulators of G protein-coupled receptor-mediated signaling processes. Their potential roles in regulating adipocyte function in vivo remain unexplored. Here we report the novel finding t...

    Sai P. Pydi, Shanu Jain, Wesley Tung, Yinghong Cui, Lu Zhu in Nature Communications (2019)

  5. No Access

    Protocol

    A Brief History of the β-Arrestins

    Arrestins have now been implicated in the actions of virtually every G protein-coupled receptor (GPCR) for which they have been examined. Originally discovered for their role in the turnoff of visual perceptio...

    Marc G. Caron, Lawrence S. Barak in Beta-Arrestins (2019)

  6. Article

    Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions

    The dopamine D2 receptor (D2R), like many G-protein-coupled receptors, signals through G-protein- and β-arrestin-dependent pathways. Preferential activation of one of these pathways is termed functional selectivi...

    Samuel J Rose, Thomas F Pack, Sean M Peterson, Kaitlin Payne in Neuropsychopharmacology (2018)

  7. Article

    Open Access

    β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions

    β-arrestins are critical signalling molecules that regulate many fundamental physiological functions including the maintenance of euglycemia and peripheral insulin sensitivity. Here we show that inactivation o...

    Lu Zhu, Joana Almaça, Prasanna K. Dadi, Hao Hong, Wataru Sakamoto in Nature Communications (2017)

  8. Article

    SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept

    Drugs, notably SSRIs, that elevate brain extracellular 5-HT (5-HTExt) are antidepressants. Unfortunately, most patients fail to remit. Multipronged clinical evidence suggests that elevating 5-HTExt beyond the SSR...

    Jacob PR Jacobsen, Meghan L Rudder, Wendy Roberts in Neuropsychopharmacology (2016)

  9. No Access

    Article

    Antidepressants at work

    Structures of the serotonin transporter protein SERT in complex with two different antidepressants shed light on how these drugs act, and point to possible targets for future drug development. See Article ...

    Marc G. Caron, Ulrik Gether in Nature (2016)

  10. Article

    Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice

    Current antipsychotic drugs (APDs) show efficacy with positive symptoms, but are limited in treating negative or cognitive features of schizophrenia. Whereas all currently FDA-approved medications target prima...

    Su M Park, Meng Chen, Claire M Schmerberg, Russell S Dulman in Neuropsychopharmacology (2016)

  11. Article

    Open Access

    A rapid and affordable screening platform for membrane protein trafficking

    Membrane proteins regulate a diversity of physiological processes and are the most successful class of targets in drug discovery. However, the number of targets adequately explored in chemical space and the li...

    Joshua C. Snyder, Thomas F. Pack, Lauren K. Rochelle in BMC Biology (2015)

  12. No Access

    Article

    The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse

    Escitalopram appears to be a superior antidepressant to racemic citalopram. It has been hypothesized that binding of R-citalopram to the serotonin transporter (SERT) antagonizes escitalopram binding to and inh...

    Jacob P. R. Jacobsen, Per Plenge, Benjamin D. Sachs, Alan L. Pehrson in Psychopharmacology (2014)

  13. Article

    Selective Deletion of GRK2 Alters Psychostimulant-Induced Behaviors and Dopamine Neurotransmission

    GRK2 is a G protein-coupled receptor kinase (GRK) that is broadly expressed and is known to regulate diverse types of receptors. GRK2 null animals exhibit embryonic lethality due to a severe developmental hear...

    Tanya L Daigle, Mark J Ferris, Raul R Gainetdinov in Neuropsychopharmacology (2014)

  14. No Access

    Article

    Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs

    The Smoothened receptor (SMO) mediates signal transduction in the hedgehog pathway, which is implicated in normal development and carcinogenesis. SMO antagonists can suppress the growth of some tumours; howeve...

    Chong Wang, Huixian Wu, Tama Evron, Eyal Vardy, Gye Won Han in Nature Communications (2014)

  15. No Access

    Article

    Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression

    Methylphenidate (MPH) is commonly diverted for recreational use, but the neurobiological consequences of exposure to MPH at high, abused doses are not well defined. Here we show that MPH self-administration in...

    Erin S. Calipari, Mark J. Ferris, Ali Salahpour, Marc G. Caron in Nature Communications (2013)

  16. Article

    A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons

    Here, we describe a newly generated transgenic mouse in which the Gs DREADD (rM3Ds), an engineered G protein-coupled receptor, is selectively expressed in striatopallidal medium spiny neurons (MSNs). We first ...

    Martilias S Farrell, Ying Pei, Yehong Wan, Prem N Yadav in Neuropsychopharmacology (2013)

  17. Article

    Open Access

    The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment

    G protein-coupled Receptor Kinase 6 (GRK6) belongs to a family of kinases that phosphorylate GPCRs. GRK6 levels were found to be altered in Parkinson's Disease (PD) and D2 dopamine receptors are supersensitive in...

    Francesca Managò, Stefano Espinoza, Ali Salahpour in Scientific Reports (2012)

  18. Article

    A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice

    Morphine is a widely used analgesic in humans that is associated with multiple untoward effects, such as addiction and physical dependence. In rodent models, morphine also induces locomotor activity. These eff...

    Nikhil M Urs, Tanya L Daigle, Marc G Caron in Neuropsychopharmacology (2011)

  19. Article

    Open Access

    Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis

    We have identified a differential gene expression profile in neural crest stem cells that is due to deletion of the norepinephrine transporter (NET) gene. NET is the target of psychotropic substances, such as ...

    Yao Fei Hu, Marc G Caron, Maya Sieber-Blum in BMC Genomics (2009)

  20. No Access

    Article

    Building a new conceptual framework for receptor heteromers

    Receptor heteromers constitute a new area of research that is resha** our thinking about biochemistry, cell biology, pharmacology and drug discovery. In this commentary, we recommend clear definitions that s...

    Sergi Ferré, Ruben Baler, Michel Bouvier, Marc G Caron in Nature Chemical Biology (2009)

previous disabled Page of 4